Literature DB >> 18256222

Escherichia coli strains of serotype O51:H40 comprise typical and atypical enteropathogenic E. coli strains and are potentially diarrheagenic.

Fabiana C Moreira1, Mônica A M Vieira, Antonio J P Ferreira, Dennys M Girão, Tânia M I Vaz, Ana Cláudia P Rosa, Terezinha Knobl, Kinue Irino, Edna Freymüller, Tânia A T Gomes.   

Abstract

Escherichia coli strains of serotype O51:H40 were studied with regard to the presence of several virulence properties and their genetic diversity and enteropathogenicity in rabbit ileal loops. This serotype encompasses potential enteropathogenic strains mostly classified as being atypical enteropathogenic E. coli (EPEC) strains, which are genetically closer to enterohemorrhagic E. coli than to typical EPEC strains.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18256222      PMCID： PMC2292968          DOI： 10.1128/JCM.01854-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  36 in total

1.  Identification of a novel genetic locus that is required for in vitro adhesion of a clinical isolate of enterohaemorrhagic Escherichia coli to epithelial cells.

Authors:  L Nicholls; T H Grant; R M Robins-Browne
Journal:  Mol Microbiol       Date:  2000-01       Impact factor: 3.501

2.  Molecular evolution of the intimin gene in O111 clones of pathogenic Escherichia coli.

Authors:  Cheryl L Tarr; Thomas S Whittam
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

3.  Identification and characterization of the locus for diffuse adherence, which encodes a novel afimbrial adhesin found in atypical enteropathogenic Escherichia coli.

Authors:  Isabel C A Scaletsky; Jane Michalski; Alfredo G Torres; Michelle V Dulguer; James B Kaper
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans.

Authors:  A W Paton; P Srimanote; M C Woodrow; J C Paton
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

5.  toxB gene on pO157 of enterohemorrhagic Escherichia coli O157:H7 is required for full epithelial cell adherence phenotype.

Authors:  I Tatsuno; M Horie; H Abe; T Miki; K Makino; H Shinagawa; H Taguchi; S Kamiya; T Hayashi; C Sasakawa
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

6.  Parallel evolution of virulence in pathogenic Escherichia coli.

Authors:  S D Reid; C J Herbelin; A C Bumbaugh; R K Selander; T S Whittam
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

7.  Phenotypic and genotypic characteristics of Escherichia coli strains of non-enteropathogenic E. coli (EPEC) serogroups that carry EAE and lack the EPEC adherence factor and Shiga toxin DNA probe sequences.

Authors:  M A Vieira; J R Andrade; L R Trabulsi; A C Rosa; A M Dias; S R Ramos; G Frankel; T A Gomes
Journal:  J Infect Dis       Date:  2001-02-08       Impact factor: 5.226

8.  An enteroaggregative Escherichia coli strain of serotype O111:H12 damages and invades cultured T84 cells and human colonic mucosa.

Authors:  C M Abe; S Knutton; M Z Pedroso; E Freymüller; T A Gomes
Journal:  FEMS Microbiol Lett       Date:  2001-09-25       Impact factor: 2.742

9.  Intimin-mediated tissue specificity in enteropathogenic Escherichia coli interaction with human intestinal organ cultures.

Authors:  A D Phillips; G Frankel
Journal:  J Infect Dis       Date:  2000-04-13       Impact factor: 5.226

Review 10.  Typical and atypical enteropathogenic Escherichia coli.

Authors:  Luiz R Trabulsi; Rogéria Keller; Tânia A Tardelli Gomes
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883
View more
  6 in total

1.  The flagella of an atypical enteropathogenic Escherichia coli strain are required for efficient interaction with and stimulation of interleukin-8 production by enterocytes in vitro.

Authors:  Suely C F Sampaio; Tânia A T Gomes; Christophe Pichon; Laurence du Merle; Stéphanie Guadagnini; Cecilia M Abe; Jorge L M Sampaio; Chantal Le Bouguénec
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

2.  Atypical enteropathogenic Escherichia coli that contains functional locus of enterocyte effacement genes can be attaching-and-effacing negative in cultured epithelial cells.

Authors:  Sérgio P D Rocha; Cecilia M Abe; Vanessa Sperandio; Silvia Y Bando; Waldir P Elias
Journal:  Infect Immun       Date:  2011-02-22       Impact factor: 3.441

3.  Adhesin-encoding genes from shiga toxin-producing Escherichia coli are more prevalent in atypical than in typical enteropathogenic E. coli.

Authors:  Tânia A T Gomes; Rodrigo T Hernandes; Alfredo G Torres; Fábia A Salvador; Beatriz E C Guth; Tânia M I Vaz; Kinue Irino; Rosa M Silva; Mônica A M Vieira
Journal:  J Clin Microbiol       Date:  2011-07-27       Impact factor: 5.948

4.  Genes related to long polar fimbriae of pathogenic Escherichia coli strains as reliable markers to identify virulent isolates.

Authors:  Alfredo G Torres; Miguel Blanco; Patricio Valenzuela; Terry M Slater; Shilpa D Patel; Ghizlane Dahbi; Cecilia López; Ximena Fernández Barriga; Jesús E Blanco; Tânia A T Gomes; Roberto Vidal; Jorge Blanco
Journal:  J Clin Microbiol       Date:  2009-06-03       Impact factor: 5.948

5.  Identification and characterization of class 1 integrons among atypical enteropathogenic Escherichia coli isolated from children under 5 years of age.

Authors:  Farzad Shahcheraghi; Fatemeh Rahmati Ghezelgeh; Saman Nobari; Elham Torabi; Seyed Fazlollah Mousavi; Mohammad Mehdi Aslani; Fereshteh Shahcheraghi
Journal:  Iran J Microbiol       Date:  2014-06

6.  Characterization of the universal stress protein F from atypical enteropathogenic Escherichia coli and its prevalence in Enterobacteriaceae.

Authors:  Cristiane S de Souza; Alfredo G Torres; Andressa Caravelli; Anderson Silva; Juliana M Polatto; Roxane M F Piazza
Journal:  Protein Sci       Date:  2016-09-23       Impact factor: 6.725
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.